CXCR4 and marginal zone lymphoma: First, CXCR4-targeted PET/CT may have the potential to emerge as a novel diagnostic reference standard in patients with MZL, including its use for disease monitoring, such as for identifying individuals prone to transformation to large B-cell lymphoma.